246 related articles for article (PubMed ID: 28506516)
1. Waning protection following 5 doses of a 3-component diphtheria, tetanus, and acellular pertussis vaccine.
Klein NP; Bartlett J; Fireman B; Aukes L; Buck PO; Krishnarajah G; Baxter R
Vaccine; 2017 Jun; 35(26):3395-3400. PubMed ID: 28506516
[TBL] [Abstract][Full Text] [Related]
2. Association of childhood pertussis with receipt of 5 doses of pertussis vaccine by time since last vaccine dose, California, 2010.
Misegades LK; Winter K; Harriman K; Talarico J; Messonnier NE; Clark TA; Martin SW
JAMA; 2012 Nov; 308(20):2126-32. PubMed ID: 23188029
[TBL] [Abstract][Full Text] [Related]
3. Waning protection after fifth dose of acellular pertussis vaccine in children.
Klein NP; Bartlett J; Rowhani-Rahbar A; Fireman B; Baxter R
N Engl J Med; 2012 Sep; 367(11):1012-9. PubMed ID: 22970945
[TBL] [Abstract][Full Text] [Related]
4. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
[TBL] [Abstract][Full Text] [Related]
5. Waning Tdap Effectiveness in Adolescents.
Klein NP; Bartlett J; Fireman B; Baxter R
Pediatrics; 2016 Mar; 137(3):e20153326. PubMed ID: 26908667
[TBL] [Abstract][Full Text] [Related]
6. Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.
Salmaso S; Mastrantonio P; Tozzi AE; Stefanelli P; Anemona A; Ciofi degli Atti ML; Giammanco A;
Pediatrics; 2001 Nov; 108(5):E81. PubMed ID: 11694665
[TBL] [Abstract][Full Text] [Related]
7. Comparative effectiveness of acellular versus whole-cell pertussis vaccines in teenagers.
Klein NP; Bartlett J; Fireman B; Rowhani-Rahbar A; Baxter R
Pediatrics; 2013 Jun; 131(6):e1716-22. PubMed ID: 23690518
[TBL] [Abstract][Full Text] [Related]
8. Duration of protection after first dose of acellular pertussis vaccine in infants.
Quinn HE; Snelling TL; Macartney KK; McIntyre PB
Pediatrics; 2014 Mar; 133(3):e513-9. PubMed ID: 24515514
[TBL] [Abstract][Full Text] [Related]
9. Diphtheria-tetanus-acellular pertussis vaccine adsorbed (Triacelluvax; DTaP3-CB): a review of its use in the prevention of Bordetella pertussis infection.
Matheson AJ; Goa KL
Paediatr Drugs; 2000; 2(2):139-59. PubMed ID: 10937466
[TBL] [Abstract][Full Text] [Related]
10. Duration of Immunity and Effectiveness of Diphtheria-Tetanus-Acellular Pertussis Vaccines in Children.
Domenech de Cellès M; Rohani P; King AA
JAMA Pediatr; 2019 Jun; 173(6):588-594. PubMed ID: 31009031
[TBL] [Abstract][Full Text] [Related]
11. Association between undervaccination with diphtheria, tetanus toxoids, and acellular pertussis (DTaP) vaccine and risk of pertussis infection in children 3 to 36 months of age.
Glanz JM; Narwaney KJ; Newcomer SR; Daley MF; Hambidge SJ; Rowhani-Rahbar A; Lee GM; Nelson JC; Naleway AL; Nordin JD; Lugg MM; Weintraub ES
JAMA Pediatr; 2013 Nov; 167(11):1060-4. PubMed ID: 24019039
[TBL] [Abstract][Full Text] [Related]
12. Waning immunity to pertussis following 5 doses of DTaP.
Tartof SY; Lewis M; Kenyon C; White K; Osborn A; Liko J; Zell E; Martin S; Messonnier NE; Clark TA; Skoff TH
Pediatrics; 2013 Apr; 131(4):e1047-52. PubMed ID: 23478868
[TBL] [Abstract][Full Text] [Related]
13. Acellular Pertussis Vaccine Effectiveness Over Time.
Zerbo O; Bartlett J; Goddard K; Fireman B; Lewis E; Klein NP
Pediatrics; 2019 Jul; 144(1):. PubMed ID: 31182549
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of Vaccination During Pregnancy to Prevent Infant Pertussis.
Baxter R; Bartlett J; Fireman B; Lewis E; Klein NP
Pediatrics; 2017 May; 139(5):. PubMed ID: 28557752
[TBL] [Abstract][Full Text] [Related]
15. A comparative efficacy trial in Germany in infants who received either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP vaccine, or DT vaccine.
Stehr K; Cherry JD; Heininger U; Schmitt-Grohé S; uberall M; Laussucq S; Eckhardt T; Meyer M; Engelhardt R; Christenson P
Pediatrics; 1998 Jan; 101(1 Pt 1):1-11. PubMed ID: 9417143
[TBL] [Abstract][Full Text] [Related]
16. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
America Academy of Pediatrics Commitee on Infectious Diseases
Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131
[TBL] [Abstract][Full Text] [Related]
17. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP).
Broder KR; Cortese MM; Iskander JK; Kretsinger K; Slade BA; Brown KH; Mijalski CM; Tiwari T; Weston EJ; Cohn AC; Srivastava PU; Moran JS; Schwartz B; Murphy TV;
MMWR Recomm Rep; 2006 Mar; 55(RR-3):1-34. PubMed ID: 16557217
[TBL] [Abstract][Full Text] [Related]
18. Diphtheria-tetanus-acellular pertussis and inactivated poliovirus vaccines given separately or combined for booster dosing at 4-6 years of age.
Black S; Friedland LR; Ensor K; Weston WM; Howe B; Klein NP
Pediatr Infect Dis J; 2008 Apr; 27(4):341-6. PubMed ID: 18316985
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of reduced antigen content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine.
Zepp F; Habermehl P; Knuf M; Mannhardt-Laakman W; Howe B; Friedland LR
Vaccine; 2007 Jul; 25(29):5248-52. PubMed ID: 17583395
[TBL] [Abstract][Full Text] [Related]
20. Duration of pertussis immunity after DTaP immunization: a meta-analysis.
McGirr A; Fisman DN
Pediatrics; 2015 Feb; 135(2):331-43. PubMed ID: 25560446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
